View in EDS

Predicting tumor response to TACE plus lenvatinib and PD-1 inhibitors for unresectable HCC: A multicenter observational study.

Saved in:
Bibliographic Details
Title: Predicting tumor response to TACE plus lenvatinib and PD-1 inhibitors for unresectable HCC: A multicenter observational study.
Authors: Deng LW; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Xie QY; Department of Hepatobiliary Surgery, the People's Hospital of Leshan, Leshan, China., Peng B; Department of Interventional Radiology, Chengdu Second People's Hospital, Chengdu, China., Zhao Y; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China., Liu B; Department of Tumor Vascular Intervention, Chengdu Qingbaijiang District People's Hospital, Chengdu, China., Feng SF; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China., Liu DX; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China., Sun YY; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Wang HQ; Department of Hepatopancreatobiliary Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Liao CL; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Wang YL; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Liu JF; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Zhang C; Department of Radiology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Chen Y; Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Xu GH; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Liu L; Department of Interventional Radiology, Chengdu Second People's Hospital, Chengdu, China., Cao L; Department of Tumor Vascular Intervention, Chengdu Qingbaijiang District People's Hospital, Chengdu, China. Electronic address: 327511253@qq.com., Wei G; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China. Electronic address: weiguo69@sohu.com., Ren Y; Department of Interventional Radiology, Chengdu Second People's Hospital, Chengdu, China. Electronic address: ir_cd_2nd_ph@sina.com., Yang XG; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China. Electronic address: yanggangxue@163.com.
Source: European journal of radiology [Eur J Radiol] 2025 Nov; Vol. 192, pp. 112401. Date of Electronic Publication: 2025 Sep 01.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Elsevier Science Ireland Ltd Country of Publication: Ireland NLM ID: 8106411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7727 (Electronic) Linking ISSN: 0720048X NLM ISO Abbreviation: Eur J Radiol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40911988
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predicting tumor response to TACE plus lenvatinib and PD-1 inhibitors for unresectable HCC: A multicenter observational study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Deng+LW%22">Deng LW</searchLink>; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Xie+QY%22">Xie QY</searchLink>; Department of Hepatobiliary Surgery, the People's Hospital of Leshan, Leshan, China.<br /><searchLink fieldCode="AU" term="%22Peng+B%22">Peng B</searchLink>; Department of Interventional Radiology, Chengdu Second People's Hospital, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Zhao+Y%22">Zhao Y</searchLink>; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Liu+B%22">Liu B</searchLink>; Department of Tumor Vascular Intervention, Chengdu Qingbaijiang District People's Hospital, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Feng+SF%22">Feng SF</searchLink>; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Liu+DX%22">Liu DX</searchLink>; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Sun+YY%22">Sun YY</searchLink>; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Wang+HQ%22">Wang HQ</searchLink>; Department of Hepatopancreatobiliary Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Liao+CL%22">Liao CL</searchLink>; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Wang+YL%22">Wang YL</searchLink>; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Liu+JF%22">Liu JF</searchLink>; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; Department of Radiology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Xu+GH%22">Xu GH</searchLink>; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Liu+L%22">Liu L</searchLink>; Department of Interventional Radiology, Chengdu Second People's Hospital, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Cao+L%22">Cao L</searchLink>; Department of Tumor Vascular Intervention, Chengdu Qingbaijiang District People's Hospital, Chengdu, China. Electronic address: 327511253@qq.com.<br /><searchLink fieldCode="AU" term="%22Wei+G%22">Wei G</searchLink>; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China. Electronic address: weiguo69@sohu.com.<br /><searchLink fieldCode="AU" term="%22Ren+Y%22">Ren Y</searchLink>; Department of Interventional Radiology, Chengdu Second People's Hospital, Chengdu, China. Electronic address: ir_cd_2nd_ph@sina.com.<br /><searchLink fieldCode="AU" term="%22Yang+XG%22">Yang XG</searchLink>; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China. Electronic address: yanggangxue@163.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228106411%22">European journal of radiology</searchLink> [Eur J Radiol] 2025 Nov; Vol. 192, pp. 112401. <i>Date of Electronic Publication: </i>2025 Sep 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ireland+Ltd%22">Elsevier Science Ireland Ltd </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>8106411 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7727 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220720048X%22">0720048X </searchLink><i>NLM ISO Abbreviation: </i>Eur J Radiol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40911988
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejrad.2025.112401
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 112401
    Titles:
      – TitleFull: Predicting tumor response to TACE plus lenvatinib and PD-1 inhibitors for unresectable HCC: A multicenter observational study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Deng LW
      – PersonEntity:
          Name:
            NameFull: Xie QY
      – PersonEntity:
          Name:
            NameFull: Peng B
      – PersonEntity:
          Name:
            NameFull: Zhao Y
      – PersonEntity:
          Name:
            NameFull: Liu B
      – PersonEntity:
          Name:
            NameFull: Feng SF
      – PersonEntity:
          Name:
            NameFull: Liu DX
      – PersonEntity:
          Name:
            NameFull: Sun YY
      – PersonEntity:
          Name:
            NameFull: Wang HQ
      – PersonEntity:
          Name:
            NameFull: Liao CL
      – PersonEntity:
          Name:
            NameFull: Wang YL
      – PersonEntity:
          Name:
            NameFull: Liu JF
      – PersonEntity:
          Name:
            NameFull: Zhang C
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Xu GH
      – PersonEntity:
          Name:
            NameFull: Liu L
      – PersonEntity:
          Name:
            NameFull: Cao L
      – PersonEntity:
          Name:
            NameFull: Wei G
      – PersonEntity:
          Name:
            NameFull: Ren Y
      – PersonEntity:
          Name:
            NameFull: Yang XG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1872-7727
          Numbering:
            – Type: volume
              Value: 192
          Titles:
            – TitleFull: European journal of radiology
              Type: main
ResultId 1